The document contains 30 multiple choice questions about good clinical practice (GCP) guidelines for investigational medicinal products (IMPs) and clinical trials. Specifically, it covers topics like the requirements for an investigator's brochure (IB), the content and sections of an investigational medicinal product dossier (IMPD), GCP guidelines on informed consent, essential documents required before starting a clinical trial, responsibilities of sponsors and investigators, and definitions of key terms and entities involved in clinical trials.